🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Recent reports have identified a specific oncogenic mutation L265P of the M...
Status
Completed
Location
UCLA Medical Center
Start Date
2014-06
Trial ID
NCT02252146
Treatments Being Tested
IMO 8400 is a second-generation oligonucleotide antagonist of endosomal Tol...
Status
Completed
Location
Centre for Human Drug Research
Start Date
2013-05
Trial ID
NCT01899729
Treatments Being Tested
The purpose of this study is to determine how safe and effective IMO-8400 i...
Status
Completed
Location
University of Alabama
Start Date
2015-11
Trial ID
NCT02612857
Treatments Being Tested
An extension study for patients who complete 24 weeks of IMO-8400 on study ...
Status
Completed
Location
Multiple Locations
Start Date
2014-11
Trial ID
NCT02363439
Treatments Being Tested
Recent reports have identified a specific oncogenic mutation L265P of the M...
Status
Terminated
Location
Cancer Centers of Excellence
Start Date
2014-03
Trial ID
NCT02092909
Treatments Being Tested